NCT00253721 Melphalan With BBBD in Treating Patients With Brain Malignancies Status TERMINATED Phase PHASE1
NCT00244868 Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer Status COMPLETED Phase PHASE3
NCT00238251 Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases Status COMPLETED Phase PHASE2
NCT00227656 Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer Status TERMINATED Phase PHASE2
NCT00182754 Octreotide in Treating Patients With Cancer-Related Malignant Ascites Status COMPLETED Phase PHASE3
NCT00134056 S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Status COMPLETED Phase PHASE3
NCT00118105 S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT00114205 Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion Status COMPLETED Phase PHASE1
NCT00110123 Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma Status TERMINATED Phase PHASE3
NCT00107367 Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor Status UNKNOWN Phase PHASE1/PHASE2
NCT00103298 Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00103142 Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00093444 Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors Status COMPLETED Phase PHASE1
NCT00089401 Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver Status COMPLETED Phase PHASE2
NCT00084825 Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008 Status COMPLETED Phase PHASE2
NCT00083616 Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy Status COMPLETED Phase PHASE2
NCT00082927 Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain Status COMPLETED Phase PHASE3
NCT00081159 Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases Status COMPLETED Phase PHASE2
NCT00080938 Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2